Correction: Blockade of the LRP16-PKR-NF-κB signaling axis sensitizes colorectal carcinoma cells to DNA-damaging cytotoxic therapy
Xiaolei Li(Anhui Medical University), Weidong Han(Zhejiang Cancer Hospital), Leena Hanski(University of Helsinki), Xiang Li(Dalian Ocean University), Xiaojing An, Miaomiao Bai(Chinese PLA General Hospital), Tero Ahola(University of Helsinki), Qian Mei(University of Florida), Zhiqiang Wu(Tibet University)
Cited by 0
Related Papers
LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b
|Journal of Translational Medicine|2015|660
New development in CAR-T cell therapy
|Journal of Hematology & Oncology|2017|409
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
|Journal of Hematology & Oncology|2018|395
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
|Journal of Hematology & Oncology|2020|320
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
|JNCI Journal of the National Cancer Institute|2016|300